Skip to content

Designing and fabricating oral Bioadhesive from Onosma Bulbotricum and study of its therapeutic effect on the patient with Recurrent Aphthous Stomatitis (RAS)

Designing and fabricating oral Bioadhesive from Onosma Bulbotricum and study of its therapeutic effect on the patient with Recurrent Aphthous Stomatitis (RAS)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130812014333N150
Enrollment
120
Registered
2020-05-26
Start date
2020-05-21
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent aphthous stomatitis. Recurrent oral aphthae

Interventions

Intervention 1: The intervention group will receive oral Bioadhesive extracted from Onosma Bulbotricum (from borage species) topically for 3 days (several times a day) for a week. Intervention 2: The

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Aphthous stomatitis occurs at least three times a year Age between 18 and 60 years

Exclusion criteria

Exclusion criteria: pregnant women

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: The second day after starting treatment as every other day for one week. Method of measurement: Based on a visual pain scale (VAS).;Number of oral lesions. Timepoint: The second day after starting treatment as every other day for one week. Method of measurement: By a specialist in oral, maxillofacial and facial diseases.;The average diameter of oral lesions. Timepoint: The second day after starting treatment as every other day for one week. Method of measurement: Using a ruler.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Reza Tahvilian

Kermanshah University of Medical Sciences

rtahvilian@kums.ac.ir+98 83 3729 6591

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026